BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27933341)

  • 1. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
    Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
    Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
    Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province.
    Fu Z; Li D; Jiang W; Wang L; Zhang J; Xu F; Pang D; Li D
    Breast Cancer Res Treat; 2010 Feb; 120(1):195-202. PubMed ID: 19585237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
    Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
    Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    M'Hidi H; Thibult ML; Chetaille B; Rey F; Bouadallah R; Nicollas R; Olive D; Xerri L
    Am J Clin Pathol; 2009 Oct; 132(4):589-96. PubMed ID: 19762537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.
    Jamroziak K; Balcerczak E; Smolewski P; Robey RW; Cebula B; Panczyk M; Kowalczyk M; Szmigielska-Kapłon A; Mirowski M; Bates SE; Robak T
    Pharmacol Rep; 2006; 58(5):720-8. PubMed ID: 17085864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.
    Jamroziak K; Szemraj Z; Grzybowska-Izydorczyk O; Szemraj J; Bieniasz M; Cebula B; Giannopoulos K; Balcerczak E; Jesionek-Kupnicka D; Kowal M; Kostyra A; Calbecka M; Wawrzyniak E; Mirowski M; Kordek R; Robak T
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):945-53. PubMed ID: 19240243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population.
    Karabon L; Jedynak A; Tomkiewicz A; Wolowiec D; Kielbinski M; Woszczyk D; Kuliczkowski K; Frydecka I
    Folia Histochem Cytobiol; 2011; 49(1):49-54. PubMed ID: 21526489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
    Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
    Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia.
    Ganster C; Neesen J; Zehetmayer S; Jäger U; Esterbauer H; Mannhalter C; Kluge B; Fonatsch C
    Genes Chromosomes Cancer; 2009 Sep; 48(9):760-7. PubMed ID: 19484764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.
    Bogunia-Kubik K; Mazur G; Urbanowicz I; Wróbel T; Kuliczkowski K; Woźniak M; Lange A
    Int J Immunogenet; 2006 Feb; 33(1):21-4. PubMed ID: 16426238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.
    Enjuanes A; Benavente Y; Bosch F; Martín-Guerrero I; Colomer D; Pérez-Alvarez S; Reina O; Ardanaz MT; Jares P; García-Orad A; Pujana MA; Montserrat E; de Sanjosé S; Campo E
    Cancer Res; 2008 Dec; 68(24):10178-86. PubMed ID: 19074885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.
    Ennas MG; Moore PS; Zucca M; Angelucci E; Cabras MG; Melis M; Gabbas A; Serpe R; Madeddu C; Scarpa A; Cocco P
    Hematol Oncol; 2008 Jun; 26(2):98-103. PubMed ID: 18271063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
    Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
    Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNR/11q#1 trinucleotide (GCC)n repeat alleles and predisposition to acute and chronic leukemia.
    Klinkov AA; Nikitin EA; Maiorova OV; Ivanov MA; Strelnikov VV; Babenko OV; Zemlyakova VV; Kuznetsova EB; Zaletayev DV
    Ann Hum Genet; 2004 Jul; 68(Pt 4):362-6. PubMed ID: 15225161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
    Asslaber D; Piñón JD; Seyfried I; Desch P; Stöcher M; Tinhofer I; Egle A; Merkel O; Greil R
    Blood; 2010 May; 115(21):4191-7. PubMed ID: 20089965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
    Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
    Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia.
    Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
    Leukemia; 2004 Nov; 18(11):1816-23. PubMed ID: 15385937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
    Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
    J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.